News About: Goverment
Government urged to support research-oriented pharmaceutical firms
The government needs to boost research-oriented pharmaceutical companies’ effort to develop new drugs by forging a special team, according to the Korea Drug Research Association.
The Korea-U.S. FTA will provide a c...
KPMA to launch anti-rebate commission next year
The Korea Pharmaceutical Manufacturers Association plans to launch a new commission dealing with the prevailing illegal business practices in the pharmaceutical industry.
The commission consists of a total of eight...
Bill to prevent doctor’s over-prescription hits snag
The National Assembly’s Health, Welfare and Family Affairs Committee rejected on November 12 a bill to get overcharged medication costs for outpatients refunded to the National Health Insurance Corporation.
The maj...
Manufacture of 400 items to be suspended
The Korea Food and Drug Administration says it will soon mete out administrative dispositions over 400 drugs that were found not to observe the small package regulation.
The punitive action was inevitable as 60 pha...
Korea’s GMP rating shows signs of improvement
The GMP rating for Korean pharmaceutical firms is seeing signs of improvement.
The Korea Food and Drug Administration said that a total of 59 pharmaceutical manufacturers were rated over “C” class.
The current ...
KFDA reviews foreign GMP facilities
The Korea Food and Drug Administration has begun to review GMP facilities of Sandoz in India to ensure the generic quality of a lipid-lowering agent, a source said recently.
The administration launched a review gro...
Doctors to benefit from incentives over substitution dispensing
A revision to the enforcement decree of the National Health Insurance Law will come into effect, following the passage from the Cabinet meeting on December 9.
The revision allows doctors to benefit from incentive, ...
Annual treatment costs showing downward trend
The nation’s rising treatment costs covered by the state health insurance has radically decreased due to the government’s strong measures, according to the Health Insurance Review and Assessment Service.
The decrea...
Waiver of GMP data for export oriented drugs eyed
The government will not require any GMP related dossiers in the approval process of export oriented drug applications as part of its efforts to boost pharmaceutical export, according to the Korea Food and Drug Adminis...
Consultative body to discuss bioequivalence of combined preparations
The government plans to set up a consultative body consisting of representatives from industry, pharmaceutical and medical camps next January to discuss the controversial issue on bioequivalence of combined preparatio...
